BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 24321472)

  • 21. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
    Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
    Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
    Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
    Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
    Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
    Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
    Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
    Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
    Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
    Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
    Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
    Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
    Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
    Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
    Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
    Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interobserver variability in the evaluation of mismatch repair protein immunostaining.
    Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M
    Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases.
    Diniz G; Aktas S; Cubuk C; Ortac R; Vergin C; Olgun N
    Pediatr Hematol Oncol; 2013 May; 30(4):273-84. PubMed ID: 23570624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma as extracolonic manifestation of Lynch syndrome indicates SEC63 as potential target gene in hepatocarcinogenesis.
    Casper M; Weber SN; Kloor M; Müllenbach R; Grobholz R; Lammert F; Zimmer V
    Scand J Gastroenterol; 2013 Mar; 48(3):344-51. PubMed ID: 23537056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.
    Sameer AS; Nissar S; Fatima K
    Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome.
    Entius MM; Keller JJ; Drillenburg P; Kuypers KC; Giardiello FM; Offerhaus GJ
    Clin Cancer Res; 2000 May; 6(5):1784-9. PubMed ID: 10815898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability, promoter methylation and protein expression of the DNA mismatch repair genes in epithelial ovarian cancer.
    V S; Bhagat R; C S P; V R P; Krishnamoorthy L
    Genomics; 2014 Oct; 104(4):257-63. PubMed ID: 25192888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
    Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
    J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microsatellite instability of bilateral breast carcinomas is not linked to down-regulated expression of DNA mismatch repair genes].
    Kuligina ESh; Morreau N; Imianitov EN
    Vopr Onkol; 2010; 56(2):152-5. PubMed ID: 20552889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome.
    Gaskin BJ; Fernando BS; Sullivan CA; Whitehead K; Sullivan TJ
    Br J Ophthalmol; 2011 Dec; 95(12):1686-90. PubMed ID: 21979897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression of mismatch repair proteins associated with acquisition of microsatellite instability in a clonal model of human T lymphocyte aging.
    Neri S; Pawelec G; Facchini A; Ferrari C; Mariani E
    Rejuvenation Res; 2008 Jun; 11(3):565-72. PubMed ID: 18484899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-level microsatellite instability in appendiceal carcinomas.
    Taggart MW; Galbincea J; Mansfield PF; Fournier KF; Royal RE; Overman MJ; Rashid A; Abraham SC
    Am J Surg Pathol; 2013 Aug; 37(8):1192-200. PubMed ID: 23648460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm.
    Everett JN; Raymond VM; Dandapani M; Marvin M; Kohlmann W; Chittenden A; Koeppe E; Gustafson SL; Else T; Fullen DR; Johnson TM; Syngal S; Gruber SB; Stoffel EM
    JAMA Dermatol; 2014 Dec; 150(12):1315-21. PubMed ID: 25006859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.